Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The current branded form, Egrifta WR, was FDA-approved in March 2025 and became available in September 2025
Clin Gastroenterol Hepatol 2025;23:739-47.ArticlePubMed 22
"At one year, weight loss is about 8%, but by three years, it's gone down to 6%," he says
Saxenda (liraglutide) Saxenda is a GLP-1 medication appropriate for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, type 2 diabetes, or high cholesterol or triglycerides It is also approved for children ages 12 and above who weigh more than 132 pounds and are considered obese
US$ 25.21
US$ 29.34
US$ 24.33
